The average of price targets set by Wall Street analysts indicates a potential upside of 28.6% in Corcept (CORT). While the effectiveness of this highly sought-after metric is questionable, the ...

The Nintendo Switch 2 will feature exclusive new versions of The Legend of Zelda: Breath of the Wild and Tears of the Kingdom ...

Perspective Therapeutics (CATX) has been on a downward spiral lately with significant selling pressure. After declining 16.6% ...

Edgewise Therapeutics (EWTX) fell 10.6% in premarket trade after it priced its offering to raise $200 million.

DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) announced a key milestone in its ACESOT-1051 clinical trial, as the ...

SNUG01 is a first-in-class targeted gene therapy that’s designed to increase the levels of TRIM72, a protein with ...

Oncologists share how to prioritize yourself while undergoing the difficult treatment, and real women share how positive ...

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

Lupin Digital Health has launched a Post-Procedure Home-Based Care Guide, developed alongside the American College of ...

First approved therapy to address hyperphagia in individuals with Prader-Willi syndrome. Management to host conference call and webcast today, March 26 th, at 5:30pm ET. REDWOOD C ...